279 related articles for article (PubMed ID: 33869767)
1. Recurrent respiratory papillomatosis: A 2020 perspective.
Benedict JJ; Derkay CS
Laryngoscope Investig Otolaryngol; 2021 Apr; 6(2):340-345. PubMed ID: 33869767
[TBL] [Abstract][Full Text] [Related]
2. Recurrent respiratory papillomatosis: update 2018.
Derkay CS; Bluher AE
Curr Opin Otolaryngol Head Neck Surg; 2018 Dec; 26(6):421-425. PubMed ID: 30300210
[TBL] [Abstract][Full Text] [Related]
3. Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis.
Intakorn P; Sonsuwan N
J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S136-41. PubMed ID: 25391185
[TBL] [Abstract][Full Text] [Related]
4. Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.
Yiu Y; Fayson S; Smith H; Matrka L
Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):309-315. PubMed ID: 30595025
[TBL] [Abstract][Full Text] [Related]
5. Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.
Smahelova J; Hamsikova E; Ludvikova V; Vydrova J; Traboulsi J; Vencalek O; Lukeš P; Tachezy R
JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):654-661. PubMed ID: 35653138
[TBL] [Abstract][Full Text] [Related]
6. Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.
Matsuzaki H; Makiyama K; Hirai R; Suzuki H; Asai R; Oshima T
Laryngoscope; 2020 Feb; 130(2):442-447. PubMed ID: 30963598
[TBL] [Abstract][Full Text] [Related]
7. Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling.
Taliercio S; Cespedes M; Born H; Ruiz R; Roof S; Amin MR; Branski RC
JAMA Otolaryngol Head Neck Surg; 2015 Jan; 141(1):78-83. PubMed ID: 25393901
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of combined approach to recurrent respiratory papillomatosis (RRP).
Aga A; Bekteshi E; Ajasllari G; Kosta A; Vajushi E; Kortoci R; Filauro M; Muka T; Peretti G
Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3693-3700. PubMed ID: 38637412
[TBL] [Abstract][Full Text] [Related]
9. Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study.
Bertino G; Pedretti F; Mauramati S; Filauro M; Vallin A; Mora F; Crosetti E; Succo G; Peretti G; Benazzo M
Acta Otorhinolaryngol Ital; 2023 Apr; 43(Suppl. 1):S111-S122. PubMed ID: 37698108
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus Vaccination as an Adjuvant Therapy for Recurrent Respiratory Papillomatosis: Additional Case Series.
Matsuzaki H; Makiyama K; Hasegawa H; Asai R; Morita M; Oshima T
J Voice; 2024 Jan; 38(1):204-209. PubMed ID: 34600799
[TBL] [Abstract][Full Text] [Related]
11. HPV and Recurrent Respiratory Papillomatosis: A Brief Review.
Ouda AM; Elsabagh AA; Elmakaty IM; Gupta I; Vranic S; Al-Thawadi H; Al Moustafa AE
Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833157
[TBL] [Abstract][Full Text] [Related]
12. The Efficacy of Human Papillomavirus Vaccination as an Adjuvant Therapy in Recurrent Respiratory Papillomatosis.
Ponduri A; Azmy MC; Axler E; Lin J; Schwartz R; Chirilă M; Dikkers FG; Yang CJ; Mehta V; Gangar M
Laryngoscope; 2023 Sep; 133(9):2046-2054. PubMed ID: 36651338
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of recurrent respiratory papillomatosis.
Larson DA; Derkay CS
APMIS; 2010 Jun; 118(6-7):450-4. PubMed ID: 20553527
[TBL] [Abstract][Full Text] [Related]
14. Current and future management of recurrent respiratory papillomatosis.
Ivancic R; Iqbal H; deSilva B; Pan Q; Matrka L
Laryngoscope Investig Otolaryngol; 2018 Feb; 3(1):22-34. PubMed ID: 29492465
[TBL] [Abstract][Full Text] [Related]
15. Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis.
Tjon Pian Gi RE; San Giorgi MR; Pawlita M; Michel A; van Hemel BM; Schuuring EM; van den Heuvel ER; van der Laan BF; Dikkers FG
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3231-6. PubMed ID: 27188508
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
Jackowska J; Piersiala K; Klimza H; Wierzbicka M
Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous Regression of Recurrent Respiratory Papillomatosis with HPV Vaccination: A Case Study.
Nyirjesy S; Osmundson P; Matrka L
J Voice; 2022 Jul; 36(4):587.e21-587.e25. PubMed ID: 32891477
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus vaccination in Africa: An airway perspective.
McGuire JK; Kabagenyi F; Peer S
Int J Pediatr Otorhinolaryngol; 2023 Feb; 165():111423. PubMed ID: 36681046
[TBL] [Abstract][Full Text] [Related]
19. Laryngotracheal Recurrent Papillomatosis: A Case Study and Survey of Surgical and Systemic Management.
Borrelli M; Nasrollahi T; Raskin J; Khan S; Alexander RE
Ear Nose Throat J; 2022 Dec; 101(10_suppl):47S-51S. PubMed ID: 36173000
[TBL] [Abstract][Full Text] [Related]
20. Systemic bevacizumab for pediatric patients with aggressive recurrent respiratory papillomatosis: One single-center experience of eight patients.
Liu Z; Xiao Y; Xu J; Liu M; Han M; Hu W; Zhu D
Laryngoscope Investig Otolaryngol; 2023 Apr; 8(2):435-440. PubMed ID: 37090874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
